ArticleFrontiers in medicine2026
Impact of inflammatory bowel disease on perioperative complications in patients undergoing surgery for metastatic spinal tumors.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The global prevalence of inflammatory bowel disease (IBD) continues to rise. However, researchers have not yet investigated how IBD influences perioperative complication rates in patients undergoing surgical intervention for metastatic spinal tumors. This study used the United States National Inpatient Sample (NIS) to evaluate the association between IBD and perioperative complications in patients undergoing surgery for metastatic spinal tumors. Methods: Patients undergoing surgical treatment for spine metastases from 2016 to 2022 were identified through ICD-10-CM diagnostic coding, and their data were analyzed. The study population excluded individuals younger than 18 years. Participants were stratified according to whether they had IBD or not, and comparisons were made across demographic characteristics, hospital-related factors, intraoperative parameters, comorbid conditions, and perioperative complications. The statistical methodology encompassed Pearson χ Results: Among 48,465 patients with metastatic spinal tumors 535 (1.1%) had concurrent IBD. Patients with IBD exhibited significantly higher odds of developing various perioperative complications. These included wound disruption (aOR = 5.41; Conclusions: Patients with IBD undergoing surgery for metastatic spinal tumors were at significantly increased risk of wound-related complications, post-procedural hematoma, postoperative infection, gastrointestinal complications, and cerebrospinal fluid leakage. These findings support careful preoperative risk stratification and individualized perioperative management in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.